The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Abstract
Objective. —To determine the relationship of brain infarction to the clinical expression of Alzheimer disease (AD). Design. —Cognitive function and the prevalence of dementia were determined for participants in the Nun Study who later died. At autopsy, lacunar and larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocortex were quantitated. Participants with abundant senile plaques and some neurofibrillary tangles in the neocortex were classified as having met the neuropathologic criteria for AD. Setting. —Convents in the Midwestern, Eastern, and Southern United States. Participants. —A total of 102 college-educated women aged 76 to 100 years. Main Outcome Measures. —Cognitive function assessed by standard tests and dementia and AD assessed by clinical and neuropathologic criteria. Results. —Among 61 participants who met the neuropathologic criteria for AD, those with brain infarcts had poorer cognitive function and a higher prevalence of dementia than those without infarcts. Participants with lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without infarcts (the odds ratio [OR] for dementia was 20.7,95% confidence interval [95% CI], 1.5-288.0). Fewer neuropathologic lesions of AD appeared to result in dementia in those with lacunar infarcts in the basal ganglia, thalamus, or deep white matter than in those without infarcts. In contrast, among 41 participants who did not meet the neuropathologic criteria for AD, brain infarcts were only weakly associated with poor cognitive function and dementia. Among all 102 participants, atherosclerosis of the circle of Willis was strongly associated with lacunar and large brain infarcts. Conclusion. —These findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia as mentioned previously.”
In the citing paper
“Furthermore, vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.”
In the citing paper
“Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.”
In the citing paper
“typically are accompanied by Alzheimer disease and other pathologies.”
In the citing paper
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
In the citing paper
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
In the citing paper
“It is now accepted that many of the traditional risk factors for stroke are also risk markers for Alzheimer disease and VCI.16,31,340,484–491”
In the citing paper
“Lacunes are frequently seen on imaging in elderly patients with no symptoms”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“are associated with an increased risk of stroke, gait impairment, and dementia.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“Cerebrovascular effects of APOE4 are associated with AD, stroke, and brain hemorrhage (314, 506, 549, 614, 693).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [549]
In the citing paper
“Classical anatomic locations for strategic infarcts include the thalamus, angular gyrus, and basal ganglia, including the caudate nucleus and globus pallidus. 52-57”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“A single small infarct may cause severe cognitive deficits when located in a strategic brain region.”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“Earlier studies have suggested a multiplicative effect between vascular and AD-type pathology on cognitive decline, 56 whereas recent studies indicate that the effects are additive. 49,100,105”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“many older individuals with dementia suffer from a combination of vascular and Alzheimer-type pathology with an additive effect on cognition,19”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [19]
In the citing paper
“On the other hand, in older individuals with moderate AD pathology subcortical vascular lesions are a major determinant of the expression of the dementia (Esiri et al., 1999; Schneider et al., 2007b; Snowdon et al., 1997).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Snowdon et al., 1997
In the citing paper
“it seems reasonable to postulate that insulin resistance and T2D could increase AD risk through cerebrovascular disease, a factor increasingly accepted to be important in AD manifestation [5, 19-21].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [5]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 301–400 of 1,644
Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
Schneider, P., Hampel, H. J., & Büerger, K. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00104.x · Cited by 154
Royall, D. R., Palmer, R., Chiodo, L. K., & Polk, M. J. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53004.x · Cited by 149
Ghafoorian, M., Karssemeijer, N., Heskes, T., Bergkamp, M. I., Wissink, J., Obels, J., Keizer, K., de Leeuw, F., van Ginneken, B., Marchiori, E., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.01.033 · Cited by 151
O'Brien, J. T. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000231780.44684.7e · Cited by 150
Mixed dementia: A review of the evidence
Custodio, N., Montesinos, R., Lira, D., Herrera-Pérez, E., Bardales, Y., & Valeriano-Lorenzo, L. (2017) · Dementia & Neuropsychologia · doi:10.1590/1980-57642016dn11-040005 · Cited by 148
New Therapeutic Targets in the Neurovascular Pathway in Alzheimer's Disease
Zloković, B. V. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.011 · Cited by 153
Naj, A. C., Beecham, G. W., Martin, E. R., Gallins, P. J., Powell, E. H., Konidari, I., Whitehead, P. L., Cai, G., Haroutunian, V. H., Scott, W. K., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001130 · Cited by 148
Beckmann, N., Schuler, A., Mueggler, T., Meyer, E. P., Wiederhold, K., Staufenbiel, M., & Krucker, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08453.2003 · Cited by 149
Snowdon, D. A., Greiner, L. H., & Markesbery, W. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06347.x · Cited by 150
Self-citationMRI Biomarkers of Vascular Damage and Atrophy Predicting Mortality in a Memory Clinic Population
Henneman, W. J. P., Sluimer, J. D., Cordonnier, C., Baak, M. M. E., Scheltens, P., Barkhof, F., & van der Flier, W. M. (2008) · Stroke · doi:10.1161/strokeaha.108.516286 · Cited by 148
Strategies for dementia prevention: latest evidence and implications
Rakesh, G., Szabo, S. T., Alexopoulos, G. S., & Zannas, A. S. (2017) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622317712442 · Cited by 164
Suemoto, C. K., Ferretti‐Rebustini, R. E. D. L., Rodriguez, R. D., Leite, R. E. P., Soterio, L., Brucki, S. M. D., Spera, R. R., Cippiciani, T. M., Farfel, J. M., Filho, A. D. P. C., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002267 · Cited by 152
Neuroinflammatory Signaling Upregulation in Alzheimer's Disease
Lukiw, W. J., & Bazan, N. G. (2000) · Neurochemical Research · doi:10.1023/a:1007627725251 · Cited by 146
Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia
Roher, A. E., Tyas, S. L., Maarouf, C. L., Daugs, I. D., Kokjohn, T. A., Emmerling, M. R., Garami, Z. F., Bëlohlávek, M., Sabbagh, M. N., Sue, L. I., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.08.228 · Cited by 148
Lewis, H. D., Beher, D., Cookson, N., Oakley, A. E., Piggott, M. A., Morris, C. M., Jaros, E., Perry, R., Ince, P. G., Kenny, R. A., et al. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00696.x · Cited by 143
Oral Microbiota and Alzheimer’s Disease: Do All Roads Lead to Rome?
Sureda, A., Daglia, M., Argüelles Castilla, S., Sanadgol, N., Fazel Nabavi, S., Khan, H., Belwal, T., Jeandet, P., Marchese, A., Pistollato, F., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104582 · Cited by 143
Vascular Aspects of Cognitive Impairment and Dementia
Wiesmann, M., Kiliaan, A. J., & Claassen, J. A. H. R. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.159 · Cited by 154
Infectious burden and cognitive function: The Northern Manhattan Study
Katan, M., Moon, Y. P., Paik, M. C., Sacco, R. L., Wright, C. B., & Elkind, M. S. V. (2013) · Neurology · doi:10.1212/wnl.0b013e3182896e79 · Cited by 141
Katon, W. J., Lin, E. H. B., Williams, L. H., Ciechanowski, P., Heckbert, S. R., Ludman, E., Rutter, C., Crane, P. K., Oliver, M., & Von Korff, M. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1248-6 · Cited by 141
Post-mortem assessment in vascular dementia: advances and aspirations
McAleese, K. E., Alafuzoff, I. I., Charidimou, A., Reuck, J. D., Grinberg, L. T., Hainsworth, A. H., Hortobágyi, T., Ince, P. G., Jellinger, K. A., Gao, J., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0676-5 · Cited by 144
Role of Hydrogen Peroxide in the Aetiology of Alzheimer??s Disease
Milton, N. G. N. (2004) · Drugs & Aging · doi:10.2165/00002512-200421020-00002 · Cited by 141
Retinal Microvascular Signs, Cognitive Function, and Dementia in Older Persons
Baker, M. L., Larsen, E. K. M., Kuller, L. H., Klein, R., Klein, R., Siscovick, D. S., Bernick, C. B., Manolio, T. A., & Wong, T. Y. (2007) · Stroke · doi:10.1161/strokeaha.107.483586 · Cited by 144
Amyloid Burden, Neuroinflammation, and Links to Cognitive Decline After Ischemic Stroke
Thiel, A., Cechetto, D. F., Heiss, W., Hachinski, V., & Whitehead, S. N. (2014) · Stroke · doi:10.1161/strokeaha.114.004285 · Cited by 139
Alzheimer disease biomarkers are associated with body mass index
Vidoni, E. D., Townley, R. A., Honea, R. A., Burns, J. M., & Initiative, A. D. N. (2011) · Neurology · doi:10.1212/wnl.0b013e318238eec1 · Cited by 140
Risk Factors for Poststroke Cognitive Decline
Levine, D. A., Wadley, V. G., Langa, K. M., Unverzagt, F. W., Kabeto, M. U., Giordani, B., Howard, G., Howard, V. J., Cushman, M., Judd, S. E., et al. (2018) · Stroke · doi:10.1161/strokeaha.117.018529 · Cited by 143
Park, L., Wang, G., Moore, J. M. R., Girouard, H., Zhou, P., Anrather, J., & Iadecola, C. (2014) · Nature Communications · doi:10.1038/ncomms6318 · Cited by 137
Ihl, R., Bachinskaya, N. Y., Korczyn, A. D., Vakhapova, V., Tribanek, M., Hoerr, R., & Napryeyenko, O. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2662 · Cited by 146
Han, B. H., Zhou, M.-L., Abousaleh, F., Brendza, R. P., Dietrich, H. H., Koenigsknecht-Talboo, J., Cirrito, J. R., Milner, E., Holtzman, D. M., & Zipfel, G. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4686-08.2008 · Cited by 138
Progression of cognitive decline before and after incident stroke
Zheng, F., Yan, L., Zhong, B., Yang, Z., & Xie, W. (2019) · Neurology · doi:10.1212/wnl.0000000000007716 · Cited by 136
Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration
Fujioka, M., Taoka, T., Matsuo, Y., Mishima, K., Ogoshi, K., Kondo, Y., Tsuda, M., Fujiwara, M., Asano, T., Sakaki, T., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10751 · Cited by 138
Risk factors for incident dementia after stroke and transient ischemic attack
Yang, J., Wong, A., Wang, Z., Liu, W., Au, L., Xiong, Y., Chu, W. W. C., Leung, E. Y. L., Chen, S., Lau, C., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.01.003 · Cited by 137
Pre-MCI and MCI: Neuropsychological, Clinical, and Imaging Features and Progression Rates
Duara, R., Loewenstein, D., Potter, E., Barker, W., Raj, A., Schoenberg, M. R., Wu, Y., Banko, J. L., Potter, H., Greig, M. T., et al. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3182107c69 · Cited by 142
The Role of B Vitamins in Preventing and Treating Cognitive Impairment and Decline
Morris, M. S. (2012) · Advances in Nutrition · doi:10.3945/an.112.002535 · Cited by 145
Age-Related Macular Degeneration and Risk for Stroke
Wong, T. Y., Klein, R., Sun, C., Mitchell, P., Couper, D. J., Lai, H. C., Hubbard, L. D., Sharrett, A. R., & Study, F. T. A. R. I. C. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-2-200607180-00007 · Cited by 139
White matter volumes and periventricular white matter hyperintensities in aging and dementia
Smith, C. D., Snowdon, D. A., Wang, H., & Markesbery, W. R. (2000) · Neurology · doi:10.1212/wnl.54.4.838 · Cited by 137
Self-citationEpidemiological of and risk factors for Alzheimer's disease: A review
Povová, J., Ambrož, P., Bar, M., Pavuková, V., Šerý, O., Tomášková, H., & Janout, V. (2012) · Biomedical Papers · doi:10.5507/bp.2012.055 · Cited by 143
Dementia risk and prevention by targeting modifiable vascular risk factors
Tariq, S., & Barber, P. A. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14132 · Cited by 140
Challenges of multimorbidity of the aging brain: a critical update
Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154
Arboix, A., & Jl, M.-V. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.2.179 · Cited by 137
Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study
Jellinger, K. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0676-3 · Cited by 135
van den Berg, E., Geerlings, M. I., Biessels, G. J., Nederkoorn, P. J., & Kloppenborg, R. P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170573 · Cited by 138
Association of arterial stiffness with progression of subclinical brain and cognitive disease
Tsao, C. W., Himali, J. J., Beiser, A., Larson, M. G., DeCarli, C. S., Vasan, R. S., Mitchell, G. F., & Seshadri, S. S. (2016) · Neurology · doi:10.1212/wnl.0000000000002368 · Cited by 132
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease
Prohovnik, I., Perl, D. P., Davis, K. L., Libow, L. S., Lesser, G. T., & Haroutunian, V. H. (2006) · Neurology · doi:10.1212/01.wnl.0000191298.68045.50 · Cited by 131
A plasticity-based theory of the pathogenesis of Alzheimer's disease.
MESULAM, M. ‐. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05559.x · Cited by 130
Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications
Levine, D. A., & Langa, K. M. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0047-z · Cited by 131
Is Hypertension Associated With an Accelerated Aging of the Brain?
Tzourio, C., Laurent, S., & Debette, S. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.00147 · Cited by 136
Different mechanisms of episodic memory failure in mild cognitive impairment
Nordahl, C. W., Ranganath, C., Yonelinas, A. P., DeCarli, C. S., Reed, B., & Jagust, W. J. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2005.01.003 · Cited by 127
Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia
Kövari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2007) · Neurology · doi:10.1212/01.wnl.0000257094.10655.9a · Cited by 128
Relationship of senescence of cerebrospinal fluid circulatory system to dementias of the aged
Rubenstein, E. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09234-9 · Cited by 127
Paganelli, R., Iorio, A. D., Patricelli, L., Ripani, F., Sparvieri, E., Faricelli, R., Iarlori, C., Porreca, E., Gioacchino, M. D., & Abate, G. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00191-7 · Cited by 128
Smallwood, A., Oulhaj, A., Joachim, C., Christie, S., Sloan, C., Smith, A. D., & Esiri, M. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01221.x · Cited by 127
Cerebrovascular disease, beta-amyloid, and cognition in aging
Marchant, N. L., Reed, B. R., DeCarli, C. S., Madison, C. M., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.001 · Cited by 127
Association of Stroke With Dementia, Cognitive Impairment, and Functional Disability in the Very Old
Zhu, L., Fratiglioni, L., Guo, Z., Agüero‐Torres, H., Winblad, B. G., & Viitanen, M. H. (1998) · Stroke · doi:10.1161/01.str.29.10.2094 · Cited by 126
Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration
Balestrini, S., Perozzi, C., Altamura, C., Vernieri, F., Luzzi, S., Bartolini, M., Provinciali, L., & Silvestrini, M. (2013) · Neurology · doi:10.1212/wnl.0b013e318295d71a · Cited by 126
Relationship of vascular risk to the progression of Alzheimer disease
Regan, C., Katona, C., Walker, Z., Hooper, J., Donovan, J., & Livingston, G. (2006) · Neurology · doi:10.1212/01.wnl.0000240129.46080.53 · Cited by 127
Cognitive impairment risk: White matter hyperintensity progression matters
Silbert, L. C., Howieson, D. B., Dodge, H., & Kaye, J. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ad53fd · Cited by 123
Khan, A., Kalaria, R. N., Corbett, A., & Ballard, C. G. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654987 · Cited by 130
The state of mental health in old‐age across the ‘old’ European Union – a systematic review
Riedel-Heller, S. G., Busse, A., & Angermeyer, M. C. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00632.x · Cited by 125
Clinical and imaging features of mixed Alzheimer and vascular pathologies
Chui, H. C., & Ramirez-Gomez, L. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0104-7 · Cited by 124
Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Oulhaj, A., Refsum, H., Beaumont, H., Williams, J. H., King, E., Jacoby, R. J., & Smith, A. D. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2303 · Cited by 124
The pathogenesis of cerebral small vessel disease and vascular cognitive impairment
Markus, H. S., & Joutel, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00028.2024 · Cited by 140
Serum estradiol and risk of stroke in elderly men
Abbott, R. D., Launer, L. J., Rodríguez, B. L., Ross, G. W., Wilson, P. W. F., Masaki, K., Strozyk, D., Curb, J. D., Yano, K., Popper, J. S., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000254473.88647.ca · Cited by 124
Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain
Staessen, J. A., Richart, T., & Birkenhäger, W. H. (2007) · Hypertension · doi:10.1161/01.hyp.0000258151.00728.d8 · Cited by 128
Anesthetic Implications of Concurrent Diseases
Roizen, M. F., & Fleisher, L. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06959-8.00035-2 · Cited by 123
The effect of white matter lesions on cognition in the elderly—small but detectable
Frisoni, G. B., Galluzzi, S., Pantoni, L., & Filippi, M. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0638 · Cited by 123
Altieri, M., Piero, V. D., Pasquini, M., Gasparini, M., Vanacore, N., Vicenzini, E., & Lenzi, G. L. (2004) · Neurology · doi:10.1212/01.wnl.0000130501.79012.1a · Cited by 121
Pharmacological Treatment of Alzheimer Disease
Massoud, F., & Léger, G. C. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105601003 · Cited by 130
Poduslo, J. F., Curran, G. L., Wengenack, T. M., Malester, B., & Duff, K. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0402 · Cited by 124
Genome instability in Alzheimer disease
Hou, Y., Song, H., Croteau, D. L., Akbari, M., & Bohr, V. A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.04.005 · Cited by 120
Circulating Biomarkers of Cognitive Decline and Dementia
Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.015 · Cited by 120
Kerrouche, N., Herholz, K., Mielke, R., Holthoff, V., & Baron, J.-C. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600296 · Cited by 120
Childhood cognitive ability and risk of late-onset Alzheimer and vascular dementia
McGurn, B., Deary, I. J., & Starr, J. M. (2008) · Neurology · doi:10.1212/01.wnl.0000319692.20283.10 · Cited by 119
Andersen‐Ranberg, K., Vasegaard, L., & Jeune, B. (2001) · The Journals of Gerontology Series B · doi:10.1093/geronb/56.3.p152 · Cited by 120
Papadopoulos, F. C., Petridou, E. T., Argyropoulou, S., Kontaxakis, V. P., Dessypris, N., Anastasiou, A., Katsiardani, K.-P., Trichopoulos, D., & Lyketsos, C. G. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1288 · Cited by 117
Assessing neuronal networks: Understanding Alzheimer's disease
Bokde, A. L. W., Ewers, M., & Hampel, H. J. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.06.004 · Cited by 120
Barnes, D. E., Haight, T., Mehta, K. M., Carlson, M. C., Kuller, L. H., & Tager, I. B. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp376 · Cited by 120
Midlife personality and risk of Alzheimer disease and distress
Johansson, L. H., Guo, X., Duberstein, P. R., Hällström, T., Wærn, M., Östling, S., & Skoog, I. G. (2014) · Neurology · doi:10.1212/wnl.0000000000000907 · Cited by 121
AD brain pathology: Vascular origins?
Launer, L. J., Petrovitch, H., Ross, G. W., Markesbery, W., & White, L. R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.008 · Cited by 117
Meta-analysis of functional network alterations in Alzheimer's disease: Toward a network biomarker
Jacobs, H. I. L., Raduà, J., Lückmann, H. C., & Sack, A. T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.009 · Cited by 116
Baker, M. L. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.30 · Cited by 114
Nelson, P. T., Abner, E. L., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Santacruz, K., Smith, C. D., Patel, E., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181aacbe9 · Cited by 115
Automatic segmentation of white matter hyperintensities in the elderly using FLAIR images at 3T
Gibson, E., Gao, F., Black, S. E., & Lobaugh, N. J. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22004 · Cited by 114
Erkinjuntti, T., Inzitari, D., Pantoni, L., Wallin, A., Scheltens, P., Rockwood, K. J., & Desmond, D. W. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06376.x · Cited by 115
Estrogen and Alzheimer’s Disease
Cholerton, B., Gleason, C., Baker, L., & Asthana, S. (2002) · Drugs & Aging · doi:10.2165/00002512-200219060-00002 · Cited by 90
Vascular Factors in Alzheimer’s Disease
Kalaria, R. N. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203008950 · Cited by 117
Xuereb, J. H., Brayne, C., Dufouil, C., Gertz, H.-J., Wischik, C. M., Harrington, C. R., Mukaetova‐Ladinska, E. B., McGee, M. A., O'SULLIVAN, A., O’Connor, D., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06404.x · Cited by 113
Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease
Popović, I. M., Šerić, V., & Demarin, V. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.029 · Cited by 113
Care and outcomes in patients with ischemic stroke with and without preexisting dementia
Saposnik, G., Côté, R., Rochon, P. A., Mamdani, M., Liu, Y., Raptis, S., Kapral, M. K., & Black, S. E. (2011) · Neurology · doi:10.1212/wnl.0b013e31823648f1 · Cited by 112
Characteristics of thein VitroVasoactivity of β-Amyloid Peptides
Crawford, F., Suo, Z., Fang, C., & Mullan, M. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6743 · Cited by 112
Helicobacter pylori and Alzheimer's disease: a possible link
Malaguarnera, M., Bella, R., Alagona, G., Ferri, R., Carnemolla, A., & Pennisi, G. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.05.008 · Cited by 112
Swartz, R. H., Sahlas, D. J., & Black, S. E. (2003) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2003.5 · Cited by 109
Silver, M. H., Newell, K. L., Brady, C. B., Hedley-White, E. T., & Perls, T. T. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200205000-00014 · Cited by 110
Intracranial atherosclerosis and dementia
Dearborn, J. L., Zhang, Y., Qiao, Y., Suri, M. F. K., Liu, L., Gottesman, R. F., Rawlings, A. M., Mosley, T. H., Alonso, Á., Knopman, D. S., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003837 · Cited by 110
McAleese, K. E., Colloby, S. J., Thomas, A. J., Al‐Sarraj, S., Ansorge, O., Neal, J., Roncaroli, F., Love, S., Francis, P. T., & Attems, J. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12291 · Cited by 110
Effect of Vascular Lesions on Cognition in Alzheimer's Disease: A Community‐Based Study
Riekse, R. G., Leverenz, J. B., McCormick, W. C., Bowen, J. D., Teri, L. L., Nochlin, D., Simpson, K., Eugenio, C. J., Larson, E. B., & Tsuang, D. W. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52405.x · Cited by 109
VITAL Trial Collaborative Group (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01154.x · Cited by 136
A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease
Crawford, F., Freeman, M. J., Schinka, J. A., Abdullah, L. I., Gold, M., Hartman, R. D., Krivian, K., Morris, M. D., Richards, D., Duara, R., et al. (2000) · Neurology · doi:10.1212/wnl.55.6.763 · Cited by 109
Education and the cognitive decline associated with MRI-defined brain infarct
Elkins, J. S., Longstreth, W. T., Manolio, T. A., Newman, A. B., Bhadelia, R. A., & Johnston, S. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228246.89109.98 · Cited by 108
Serrano‐Pozo, A., Qian, J., Monsell, S. E., Frosch, M. P., Betensky, R. A., & Hyman, B. T. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000016 · Cited by 106
White, C. C., Yang, H., Yu, L., Chibnik, L. B., Dawe, R. J., Yang, J., Klein, H., Felsky, D., Ramos‐Miguel, A., Arfanakis, K., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002287 · Cited by 105
Metadata
- Authors
- Snowdon, D. A.
- Corresponding author
- Snowdon, David A.
- ORCID
- Snowdon, David A.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-12
- Volume
- 277
- Issue
- 10
- Pages
- 813
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4296588155
- Cited by
- 1,590
- References
- 0
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 30 · 2023: 39 · 2022: 43 · 2021: 42 · 2020: 51 · 2019: 57 · 2018: 52 · 2017: 60 · 2016: 74 · 2015: 63 · 2014: 71 · 2013: 61 · 2012: 74
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Funders
- National Institute on Aging (R01AG009862, P50AG005144, KO4AG00553)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebral infarction, lacunar infarction, dementia, cognitive function, amyloid plaques, neurofibrillary tangles, cerebrovascular disease, atherosclerosis, circle of Willis, thalamic infarction, basal ganglia infarcts, older women, neuropathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
